|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net increase in net assets resulting from operations | ||||
| Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities: | ||||
| Purchases of investments | ||||
| Proceeds from sales and repayments of investments | ||||
| Net change in unrealized depreciation (appreciation) on investments | ||||
| Net change in unrealized (appreciation) depreciation on foreign currency translations | ||||
| Increase in investments due to payment-in-kind income | ||||
| Amortization of premium and accretion of discount, net | ||||
| Deferred tax (benefit) provision | ||||
| Amortization of loan structure fees | ||||
| Amortization of deferred financing costs | ||||
| Amortization of discount on Notes Payable | ||||
| Amortization of premium on Notes Payable | ||||
| Amortization of loan fees on SBA-guaranteed debentures | ||||
| Net realized (gain) loss on investments | ||||
| Loss on debt extinguishment | ||||
| Changes in other assets and liabilities | ||||
| Increase in interest receivable | ||||
| (Increase) decrease in income tax receivable | ||||
| Decrease (increase) in other receivables | ||||
| Decrease (increase) in related party receivables | ||||
| Decrease (increase) in prepaid expenses | ||||
| Increase (decrease) in management fees payable | ||||
| (Decrease) increase in income incentive fees payable | ||||
| Decrease in capital gains incentive fees payable | ||||
| Increase (decrease) in administrative services payable | ||||
| Increase in interest payable | ||||
| Decrease in related party payable | ||||
| Increase in unearned revenue | ||||
| Decrease in income tax payable | ||||
| (Decrease) increase in other accrued expenses and liabilities | ||||
| Net Cash Used in Operating Activities | ||||
| Cash Flows from Financing Activities | ||||
| Proceeds from the issuance of common stock | ||||
| Sales load for common stock issued | ||||
| Offering costs paid for common stock issued | ||||
| Stockholder distributions paid | ||||
| Proceeds from SBA-guaranteed debentures | ||||
| Proceeds from issuance of Notes Payable | ||||
| Repayment of Notes Payable | ||||
| Financing costs paid on Notes Payable | ||||
| Repayments of SBA-guaranteed debentures | ||||
| Financing costs paid on SBA-guaranteed debentures | ||||
| Financing costs paid on Credit Facility | ||||
| Borrowings under Credit Facility | ||||
| Repayments of Credit Facility | ||||
| Net Cash Provided (Used) by Financing Activities | ||||
| Net Increase (Decrease) in Cash and Cash Equivalents | ||||
| Cash and Cash Equivalents Balance at Beginning of Period | ||||
| Cash and Cash Equivalents Balance at End of Period | ||||
| Supplemental and Non-Cash Activities | ||||
| Cash paid for interest expense | ||||
| Income and excise tax paid | ||||
| (Decrease) increase in distributions payable | ||||
| (Decrease) increase in deferred offering costs | ||||
| Exchange of investments |
Loading...
